Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Global Regulatory Systems

Global Regulatory Systems

Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...

Drug Control Governance: Regulatory Bodies and Their Impact

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Ethical Issues

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:

Standards of Care II

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:

Standards of Care I

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

For Autoimmune Ills, Biologics Bring Promise-And Problems.

Managed care (Langhorne, Pa.)·2017

Same author

Biosimilar Research Proceeds in Cancer, RA, and Hep B.

Managed care (Langhorne, Pa.)·2016

Same author

Biosimilars in Development Near End of Phase 3 Trials.

Managed care (Langhorne, Pa.)·2016

Same author

Digital Health Technology Adoption Depends On Tech Comfort Level, Willingness to Pay.

Managed care (Langhorne, Pa.)·2016

Same author

New Cancer Drugs Shine, but Costs May Dim Luster.

Managed care (Langhorne, Pa.)·2015

Same author

Sure, They're Cool, but Will Smart Wearables Ever Live Up to Their Potential?

Managed care (Langhorne, Pa.)·2015

Same journal

Big pharma moves into biologics.

Biotechnology healthcare·2013

Same journal

Study: High Copayments Cut Biodrug Use up to 21 Percent.

Biotechnology healthcare·2013

Same journal

Avian flu and the quest for immunity: not just chicken feed.

Biotechnology healthcare·2013

Same journal

Variety of Biotech Therapies, Uses Take Prominence Among ASCO Presentations.

Biotechnology healthcare·2013

Same journal

Opening the door to follow-on proteins?

Biotechnology healthcare·2013

Same journal

On specialty pharmaceuticals: reflections of a second-year medical student.

Biotechnology healthcare·2013

See all related articles

Search research articles

Related Experiment Videos

4 regulatory issues to watch.

Katherine T Adams

Biotechnology Healthcare

|February 9, 2013

Summary

This summary is machine-generated.

Future biotechnology will be shaped by biologic follow-on drugs, pharmacogenomics, patient privacy regulations like HIPAA, and FDA policies. These factors will significantly influence the industry's direction.

Related Experiment Videos

Area of Science:

Biotechnology
Genomics
Regulatory Science

Background:

The biotechnology sector is evolving rapidly, influenced by scientific advancements and regulatory landscapes.
Emerging technologies like pharmacogenomics offer personalized medicine but raise data privacy concerns.
The development of biologic follow-on drugs presents both opportunities and challenges for market access and innovation.

Purpose of the Study:

To analyze the key factors influencing the future trajectory of the biotechnology industry.
To examine the interplay between scientific innovation, regulatory frameworks, and market dynamics.
To provide insights into the strategic considerations for stakeholders in the biotechnology sector.

Main Methods:

Literature review of current trends in biotechnology, pharmacogenomics, and regulatory affairs.
Analysis of FDA guidance documents and policy statements.
Examination of legal and ethical considerations surrounding patient data privacy (HIPAA).

Main Results:

Biologic follow-on drugs are poised to impact market competition and therapeutic accessibility.
Pharmacogenomics integration requires robust data management and privacy protocols.
FDA's evolving regulatory stance will be critical for approving novel biotechnologies and follow-on products.

Conclusions:

The future of biotechnology is contingent upon navigating complex interactions between scientific innovation, pharmacogenomic applications, data privacy (HIPAA), and FDA regulations.
Strategic adaptation to these forces is essential for sustained growth and development in the biotechnology landscape.